Bond Pet Foods wins FDA nod for precision-fermented lamb protein

Bond Pet Foods has crossed the regulatory threshold that turns precision-fermented protein from a promising formulation into something closer to a commercial ingredient. On May 12, 2026, the company said the FDA Center for Veterinary Medicine issued a Letter of No Objection for Lamb Protein Yeast, the first animal protein made through precision fermentation in its Hill’s Pet Nutrition collaboration to clear that review path.

The ingredient was backed by a six-month longitudinal feeding study in dogs and is intended for use at inclusion levels of up to 15% of finished food for healthy adult dogs. Bond said Lamb Protein Yeast delivers a complete amino acid profile and nutritional characteristics comparable to traditional lamb protein. In pet food, that kind of validation matters because the category runs on more than novelty: buyers want proof that an ingredient can support palatability, nutrition and consistency at scale.

The significance of the letter sits in the FDA’s GRAS framework, which can end with a response in which the agency does not question a notifier’s GRAS conclusion. The FDA also maintains a public inventory of animal-food GRAS notices and response letters, listing the notifier, substance, intended use, intended species, filing date and the agency’s response. For Bond and Hill’s, that means the conversation has moved beyond whether the ingredient belongs in the market to how far and how fast it can be used.

That shift has been building for years. Hill’s and Bond announced their collaboration in late 2021. In February 2024, Bond shipped the first two metric tons of fermentation-derived animal protein to Hill’s, a batch produced from a 45,000-liter run and sent to the Hill’s Pet Nutrition Center in Topeka, Kansas for formulation work, regulatory review and market evaluation. Bond and Hill’s are still preparing additional information for FDA submission related to feline use, signaling that the dogs’ green light is only one step in a broader rollout.

The broader company context reinforces how much credibility this milestone carries. Yvonne Hsu became president of Hill’s Pet Nutrition on July 1, 2025, succeeding John Hazlin, who moved to chief growth officer at Colgate-Palmolive. Bond founder and CEO Rich Kelleman has framed the company’s mission around animal-identical proteins for pet nutrition through precision fermentation, and the partnership has already extended to a second joint development agreement for another animal protein.

For alternative proteins, the lesson is plain: regulatory validation is the real inflection point. When an incumbent like Hill’s keeps testing, and the FDA says it has no objection, precision fermentation stops looking like a concept and starts looking like a supply chain.